Article
Trials and tribulations of highly effective modulator therapies in cystic fibrosis.
Paediatric respiratory reviews - 1 Dec 2023
Lieu Nathan, Prentice Bernadette J, Field Penelope, Fitzgerald Dominic A
Abstract excerpt
Highly effective modulator therapies (HEMTs) have revolutionised the management approach of most patients living with cystic fibrosis (CF) who have access to these therapies. Clinical trials have reported significant improvements across multiorgan systems, with patients surviving longer. However, there are accumulating case reports and observational data describing various adverse events following initiation of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
